• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Biogen Inc. (BIIB)

    -NasdaqGS
    303.69 Down 0.80(0.26%) Aug 28, 4:00PM EDT
    |After Hours : 303.55 Down 0.14 (0.05%) Aug 28, 4:57PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.1
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:389.27
    Median Target:385.00
    High Target:494.00
    Low Target:291.00
    No. of Brokers:15

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Aug 11, 2015H.C. WainwrightInitiated Buy
    Jul 27, 2015BernsteinUpgradeMkt PerformOutperform
    Jul 27, 2015Robert W. BairdDowngradeOutperformNeutral
    Jul 24, 2015BMO Capital MarketsDowngradeOutperformMarket Perform
    Jul 22, 2015Piper JaffrayDowngradeOverweightNeutral
    Jul 14, 2015BofA/MerrillUpgradeNeutralBuy
    Jun 9, 2015GuggenheimInitiated Neutral
    Mar 23, 2015StifelDowngradeBuyHold
    Oct 22, 2014Robert W. BairdUpgradeNeutralOutperform
    Oct 30, 2013FBR CapitalInitiated Mkt Perform

    More Upgrades & Downgrades for BIIB

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy5446
    Buy89910
    Hold8776
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.